AU1122300A - Pharmaceutical formulations useful to treat inflammatory and immune disorders - Google Patents

Pharmaceutical formulations useful to treat inflammatory and immune disorders

Info

Publication number
AU1122300A
AU1122300A AU11223/00A AU1122300A AU1122300A AU 1122300 A AU1122300 A AU 1122300A AU 11223/00 A AU11223/00 A AU 11223/00A AU 1122300 A AU1122300 A AU 1122300A AU 1122300 A AU1122300 A AU 1122300A
Authority
AU
Australia
Prior art keywords
pharmaceutical formulations
immune disorders
treat inflammatory
formulations useful
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11223/00A
Inventor
Mukund S. Chorghade
Gordon J. Dow
Robert W. Lathrop
Alla Verkata Rama Rao
C. Grace Yeh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LeukoSite Inc
Original Assignee
LeukoSite Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LeukoSite Inc filed Critical LeukoSite Inc
Publication of AU1122300A publication Critical patent/AU1122300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU11223/00A 1998-10-16 1999-10-15 Pharmaceutical formulations useful to treat inflammatory and immune disorders Abandoned AU1122300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17390398A 1998-10-16 1998-10-16
US09173903 1998-10-16
PCT/US1999/024361 WO2000023071A1 (en) 1998-10-16 1999-10-15 Pharmaceutical formulations useful to treat inflammatory and immune disorders

Publications (1)

Publication Number Publication Date
AU1122300A true AU1122300A (en) 2000-05-08

Family

ID=22634006

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11223/00A Abandoned AU1122300A (en) 1998-10-16 1999-10-15 Pharmaceutical formulations useful to treat inflammatory and immune disorders

Country Status (3)

Country Link
EP (1) EP1123095A1 (en)
AU (1) AU1122300A (en)
WO (1) WO2000023071A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10121252A1 (en) * 2001-04-30 2002-11-07 Christos C Zouboulis Acne treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5463083A (en) * 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders

Also Published As

Publication number Publication date
EP1123095A1 (en) 2001-08-16
WO2000023071A1 (en) 2000-04-27
WO2000023071A9 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
AU7132998A (en) Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU2002300464A1 (en) Apoliprotein A-I Agonist And Their Use To Treat Dyslipidemic Disorders
AU4229200A (en) Methods and compositions for treating dermatological disorders with fruit extracts
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU4905499A (en) Topical aciclovir formulations
AU3472799A (en) Dermatological formulations and methods
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU2036297A (en) Topical formulations of aciclovir
AU1847695A (en) Pharmaceutical formulations of cntf
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU2001229597A1 (en) Compositions and methods to treat neurodegenerative disorders
AU1568999A (en) Pharmaceutical compositions based on dalforpristin and quinupristin and preparation
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU8671798A (en) Methods and compositions relating to no-mediated cytotoxicity
AU6281298A (en) Use of lofexidine in the treatment of behavioral disorders
AU1122300A (en) Pharmaceutical formulations useful to treat inflammatory and immune disorders
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
AU5446798A (en) Compositions and methods for the treatment of gastrointestinal disorders
AU7622798A (en) Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes
IL136635A0 (en) Pharmaceutical formulations and processes for their preparation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase